Vitruvian Partners’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.8M Sell
450,000
-56,599
-11% -$4.96M 38.62% 1
2026
Q2
$42M Sell
506,599
-743,401
-59% -$40.4M 35.79% 1
2026
Q1
$48.2M Hold
1,250,000
– – 43.09% 1
2025
Q4
$58.1M Hold
1,250,000
– – 41.73% 1
2025
Q3
$61.4M Hold
1,250,000
– – 42.55% 1
2025
Q2
$64.7M Buy
+1,250,000
New +$50.5M 39.39% 1

Other funds holding HNGE

Vitruvian Partners's HNGE Position: Q3 2026 in Review

Vitruvian Partners reduced its Hinge Health (HNGE) stake by 11% in Q3 2026, selling an estimated $4.96M and leaving 450,000 shares worth $43.8M. The position accounts for 38.62% of the portfolio, ranked #1.

Vitruvian Partners first reported a position in HNGE in Q2 2025 and has held it in 6 quarters since. The position peaked at $64.7M in Q2 2025. 368 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.

  • Vitruvian Partners held 450,000 shares of Hinge Health worth $43.8M as of Q3 2026.
  • Vitruvian Partners sold 56,599 Hinge Health shares in Q3 2026, an estimated $4.96M.
  • Hinge Health made up 38.62% of Vitruvian Partners's portfolio in Q3 2026, its #1 holding.
  • Vitruvian Partners first reported a position in Hinge Health in Q2 2025 and has held it in 6 quarters since.
  • Vitruvian Partners's Hinge Health position peaked at $64.7M in Q2 2025.
  • 368 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.

Based on Vitruvian Partners's 13F filing for Q3 2026, filed 13 Nov 2026.